Staging for CLL-type non-Hodgkin's lymphoma reveals a gastrointestinal stromal tumour

Netherlands Journal of Medicine

Volumn 63, Issue 2, 2005, Pages 74-75

  Herbers, A H E ^a   Keuning, J J ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MÁXIMA MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; IMATINIB; STEM CELL FACTOR RECEPTOR;

AGED; ARTICLE; AXILLARY LYMPH NODE; BONE MARROW EXAMINATION; CANCER STAGING; CASE REPORT; CERVICAL LYMPH NODE; CHRONIC LYMPHATIC LEUKEMIA; COMPUTER ASSISTED TOMOGRAPHY; FATIGUE; GASTROINTESTINAL STROMAL TUMOR; GASTROSCOPY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE BIOPSY; LYMPHADENOPATHY; MALE; NONHODGKIN LYMPHOMA; POSITRON EMISSION TOMOGRAPHY; STERNOCLEIDOMASTOID MUSCLE; WEIGHT REDUCTION;

AGED; BIOPSY, NEEDLE; DIAGNOSIS, DIFFERENTIAL; FOLLOW-UP STUDIES; GASTROINTESTINAL STROMAL TUMORS; GASTROSCOPY; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LYMPHOMA, NON-HODGKIN; MALE; NEOPLASM STAGING; PIPERAZINES; PYRIMIDINES; RISK ASSESSMENT; STOMACH NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 14844297699     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Cerny T, Gilessen S. Advances in the treatment of Non-Hodgkin's Lymphoma. Ann Oncol 2002;13(suppl 4):211-6.
2. Joensuu H, Fletcher C, Dimitryevic S, Silberman S, Roberts P, Demetri G. Management of malignant gastrointestinal stromal tumours. Lancet Oncol 2002;3:655-64.
3. Singer S, Rubin BP, Lux ML, et al. Prognostic value of KIT mutation type, mitotic activity, and histologic subtype in gastrointestinal stromal tumors. J Clin Oncol 2002;20:3898-905.
4. Gelderblom H, Hogedoorn PCW, van der Graaf WTA, Verweij J. Imatinib, een specifieke tyrosinekinaseremmer, voor de behandeling van patiënten met een gastro-intestinale stromaceltumor. Ned Tijdschr Geneeskd 2003;147(42):2051-5.
5. Heinrich MC, Blanke CD, Druker BJ, Corless CL. Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignancies. J Clin Oncol 2002;20:1692-703.
6. Judson I. Gastrointestinal stromal tumours (GIST): biology and treatment. Ann Oncol 2002;13(suppl 4):287-9.
7. Demetri GD. Targeting the molecular pathophysiology of gastrointestinal stromal tumors with imatinib. Mechanisms, successes and challenges to rational drug development. Hematol Oncol Clin North Am 2002;16:1115-24.